Treatment.com AI Engages Marketing Services Providers
Treatment.com AI (OTC: TREIF) has announced strategic marketing partnerships with two service providers to enhance its digital presence and investor awareness. The company has engaged 45 Degrees Inc. for a six-month digital marketing campaign at USD $180,000, with potential monthly extensions at $25,000.
Additionally, Treatment.com has partnered with Investment Publishing LLC for a one-year investor relations strategy enhancement program. As compensation, the company has issued 400,000 stock options each to both service providers' principals, exercisable at $0.45 per share for three years. The company has also granted an additional 400,000 options to arm's length consultants under the same terms.
Treatment.com AI (OTC: TREIF) ha annunciato partnership strategiche di marketing con due fornitori di servizi per migliorare la sua presenza digitale e la consapevolezza degli investitori. L'azienda ha ingaggiato 45 Degrees Inc. per una campagna di marketing digitale della durata di sei mesi al costo di 180.000 USD, con possibili rinnovi mensili a 25.000 USD.
Inoltre, Treatment.com ha stretto una collaborazione con Investment Publishing LLC per un programma annuale di potenziamento della strategia di relazioni con gli investitori. Come compenso, la società ha emesso 400.000 stock option a ciascuno dei principali rappresentanti di entrambi i fornitori di servizi, esercitabili a 0,45 USD per azione per tre anni. La società ha inoltre concesso ulteriori 400.000 opzioni a consulenti indipendenti alle stesse condizioni.
Treatment.com AI (OTC: TREIF) ha anunciado alianzas estratégicas de marketing con dos proveedores de servicios para mejorar su presencia digital y la conciencia de los inversores. La compañía ha contratado a 45 Degrees Inc. para una campaña de marketing digital de seis meses por 180,000 USD, con posibles extensiones mensuales a 25,000 USD.
Además, Treatment.com se ha asociado con Investment Publishing LLC para un programa anual de mejora de la estrategia de relaciones con inversores. Como compensación, la compañía ha emitido 400,000 opciones sobre acciones a cada uno de los principales representantes de ambos proveedores de servicios, ejercitables a 0.45 USD por acción durante tres años. La compañía también ha otorgado 400,000 opciones adicionales a consultores independientes bajo los mismos términos.
Treatment.com AI (OTC: TREIF)는 디지털 존재감 및 투자자 인지도를 강화하기 위해 두 개의 서비스 제공업체와 전략적 마케팅 파트너십을 발표했습니다. 회사는 45 Degrees Inc.와 6개월 간의 디지털 마케팅 캠페인을 위해 180,000달러를 계약했으며, 월별 연장 시 25,000달러가 추가될 수 있습니다.
또한 Treatment.com은 투자자 관계 전략 강화 프로그램을 위해 Investment Publishing LLC와 1년간 파트너십을 체결했습니다. 보상으로 회사는 두 서비스 제공업체 주요 인사 각각에게 400,000 주식 옵션을 발행했으며, 주당 0.45달러에 3년간 행사할 수 있습니다. 회사는 동일 조건으로 독립 컨설턴트에게도 추가로 400,000 옵션을 부여했습니다.
Treatment.com AI (OTC : TREIF) a annoncé des partenariats stratégiques en marketing avec deux prestataires de services afin d'améliorer sa présence digitale et la notoriété auprès des investisseurs. La société a engagé 45 Degrees Inc. pour une campagne de marketing digital de six mois au coût de 180 000 USD, avec des prolongations mensuelles possibles à 25 000 USD.
De plus, Treatment.com s’est associée à Investment Publishing LLC pour un programme d'amélioration de la stratégie de relations investisseurs d'une durée d'un an. En contrepartie, la société a émis 400 000 options d'achat d'actions à chacun des principaux responsables des deux prestataires, exerçables à 0,45 USD par action pendant trois ans. La société a également accordé 400 000 options supplémentaires à des consultants indépendants aux mêmes conditions.
Treatment.com AI (OTC: TREIF) hat strategische Marketingpartnerschaften mit zwei Dienstleistern angekündigt, um seine digitale Präsenz und das Investorenbewusstsein zu stärken. Das Unternehmen hat 45 Degrees Inc. für eine sechsmonatige digitale Marketingkampagne zu einem Preis von 180.000 USD engagiert, mit möglichen monatlichen Verlängerungen zu 25.000 USD.
Zusätzlich hat Treatment.com eine Partnerschaft mit Investment Publishing LLC für ein einjähriges Programm zur Verbesserung der Investor-Relations-Strategie geschlossen. Als Vergütung hat das Unternehmen beiden Dienstleistern jeweils 400.000 Aktienoptionen gewährt, die zu 0,45 USD pro Aktie für drei Jahre ausgeübt werden können. Zudem wurden weiteren unabhängigen Beratern unter denselben Bedingungen 400.000 Optionen gewährt.
- Company is investing in expanding its digital marketing presence and investor awareness
- Marketing agreements include comprehensive digital strategy including Google Ads, social media, and video distribution
- Flexible terms allow for monthly extensions and service scope expansion
- Significant equity dilution through issuance of 1.2 million total stock options
- Substantial marketing expenses with USD $180,000 initial commitment
- Heavy reliance on external marketing services providers for growth
VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce that it has engaged 45 Degrees, Inc. (“45 Degrees”) and Investment Publishing LLC (“Investment Publishing”) to provide digital marketing and investor awareness services on behalf of Treatment as further described below.
45 Degrees:
45 Degrees of Cheyenne, WY, has been engaged by Treatment for a six-month term commencing immediately to provide advertising services including Google Ads, social media and video interview distribution (the “Marketing Engagement”). The Marketing Engagement was entered into on July 18, 2025, in consideration of a total fee of USD
In connection with and as partial consideration for the Marketing Engagement, Treatment has issued400,000 stock options (each an “Option”) to the principal of 45 Degrees, which shall each be exercisable at
Investment Publishing:
The Company has also engaged Investment Publishing pursuant to a marketing agreement dated July 18, 2025 to enhance the Company’s investor relations strategy. The engagement of Investment Publishing is for an initial one year term commencing immediately and is designed to increase awareness of the Company. Investment Publishing will aim to engage investors through public relations efforts, educational content, and direct outreach using a range of digital platforms, including social media channels, email newsletters, and investor-focused webinars. As compensation for services to be provided, the Company will pay Investment Publishing, the Company will issue Investment Publishing’s principal, Mariusz Skonieczny, 400,000 Options, which are each exercisable to acquire one common share of the Company at an exercise price of
Option Grants
The Company also announces that it has granted an aggregate of an additional 400,000 Options to certain arm’s length consultants to the Company pursuant to the Company’s stock option plan. Such Options, which vest immediately, are exercisable at an exercise price of
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment.com AI has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment.com AI’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
ehamza@treatment.com
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements that are based on Treatment’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. These forward-looking statements or information may relate to the engagement of 45 Degrees and Investment Publishing and the anticipated benefits to Treatment from such engagement. Although Treatment believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
